Molecular Imaging Market
Increasing preference for non-invasive and pain free surgeries to encourage Molecular Imaging uptake in the coming decade
Molecular Imaging Market by Modality, End User, Application & Region - Forecast 2022 - 2032
Molecular Imaging Market Snapshot (2022-2032)
[301 Pages Report] The global molecular imaging market is expected to secure US$ 4.31 Billion in 2022. During the forecast period of 2022-2032, the market is projected to exhibit a CAGR of 5.41% while garnering US$ 7.3 Billion. The growth of the market can be attributed to the increasing incidences of chronic illness across the globe.
The increasing prevalence of chronic diseases like cancer and other genetic illness are expected to propel the demand for an efficient and early disease diagnosis, which is projected to benefit the global molecular imaging market during the forecast period.
Increasing adoption of molecular imaging for new applications, ongoing development and innovation in molecular imaging technologies, and developing economies are likely to provide significant opportunities for growth in the market in the coming time.
|
Data Points |
Key Statistics |
|
Expected Market Value (2022) |
US$ 4.31 Billion |
|
Anticipated Forecast Value (2032) |
US$ 7.3 Billion |
|
Projected Growth Rate (2022-2032) |
5.41% |
Furthermore, molecular imaging procedures have various benefits which are projected to augment the molecular imaging market. Molecular imaging procedures are non-invasive, safe, and painless and are used to treat heart diseases, cancer, and disorders like Alzheimer’s and Parkinson’s disease, kidney and thyroid disorders, and others. Early detection of the diseases allows treatment on time when there may be a better prognosis.
Additionally, the introduction of new devices is likely to augment the market size during the forecast period. In January 2021, Molecular Devices LLC., a renowned provider of high-performance life science technology, launched its next-generation, high-content imaging system.
The new system provides faster image acquisition and multiplexing flexibility with high-performance lasers. Image analysis with machine learning will allow researchers to quickly uncover new insights that are provable and repeatable with clarity, and accuracy. Such initiatives are expected to benefit the market growth in the forecast period.
Let us know your requirement to get
100% FREE customization
Global Molecular Imaging Market Revenue Analysis 2017-2021 Vs Future Outlook 2022-2032
From 2017-2021, the global molecular imaging market is expected to have displayed a CAGR of 4.8%. Expansion during the given time frame can be attributed to the growing demand for early detection tools, growth initiatives, and reimbursement initiatives undertaken by the government.
Also, the introduction of advanced equipment is another factor that is likely to have participated in market development. For instance, in August 2020, Philips expanded its cardiovascular ultrasound portfolio by launching Affiniti CVs. Attributed to such factors, the market is likely to have displayed growth opportunities in the aforementioned forecast period.
During the forecast period of 2022-2032, the global molecular imaging market is anticipated to display a CAGR of 5.14%. The development of the market can be attributed to the introduction of advanced technologies. For instance, in 2021, GE Healthcare, a US-based player, launched Venue Fit.
It is a streamlined and compact POCUS system, along with the industry’s first AI offering for cardiology. Such initiatives are expected to benefit the market during the assessment tenure.
What Are The Prominent Factors In The Global Molecular Imaging Market?
Introduction of Advanced Equipment to Favor Market Growth
Increasing demand for early detection and cost-effective diagnosis of chronic diseases along with the rising geriatric population across the globe are likely to fuel demand for the molecular imaging system. The advent of modern devices and developing healthcare infrastructure in evolving economies are some of the salient factors escalating market growth.
The launch of AI-based devices is projected to augment the market size in the coming time. For instance, in May 2020, Fujifilm Corporation launched AI-based technology for lung nodule detection. This technology is used to detect pulmonary nodules in chest CT scans to aid in lung cancer detection.
In another instance, in November 2020, Canon Medical Systems Corporation launched One-Beat Spectral Cardiac CT, with rapid kVp switching and deep learning spectral reconstruction to acquire whole-heart spectral images in one beat. Thus, the launch of advanced products is anticipated to benefit the industry during the forecast period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat Are The Factors Hindering The Global Molecular Imaging Market?
Expenses Associated with Molecular Imaging System to Hinder the Market
High expenses associated with advanced molecular imaging system is projected to hamper the market growth during the forecast period. The presence of unfavorable reimbursements and lack of expertise in developing countries can hinder the market growth.
However, the rapid growth of the geriatric population, and growing cases of Alzheimer’s disease, arthritis, dementia, and Parkinson’s disease, are expected to escalate the demand for molecular imaging devices, thus, benefitting the industry in the forecast period.
What Are The Key Trends In The Global Molecular Imaging Market?
AI-Based Medical Equipment to Offer Remunerative Opportunities to the Molecular Imaging Market
The increasing application of AI-based diagnostic equipment for the rapid detection of illnesses is anticipated to act as a significant opportunity for the global molecular imaging market during the forecast period. Players in the market are introducing AI-based equipment which will help the market in fetching significant dividends.
In 2019, Siemens Healthineers introduced an ultrasound system, Acuson Redwood, which provides an imaging solution for clinical departments including cardiology, radiology, and gynecology.
Also, growing approvals of products by authorities can further benefit the market. For instance, in December 2020, Hologic, Inc., announced that the U.S FDA had approved Genius AI Detection technology for early detection of breast cancer. The advent of AI-based devices is projected to benefit the market in the coming time.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Segmentation Analysis
Why is the Hospital Segment Dominating the Global Molecular Imaging Market?
Availability of Modern Equipment in Hospitals to Boost the Segment Growth
As per the analysis, based on end-users, the hospital segment is anticipated to dominate the global molecular imaging market. In 2021, the segment is projected to have claimed 46.5% of the global revenue.
Increasing demand for modern techniques and the availability of advanced services are likely to benefit the segmental growth during the forecast period. Developed countries have shown a significant rise in demand for such setups. Attributed to such factors, the segment is projected to grow significantly in the forecast period.
What is the Participation of Diagnostic Centers to Augment the Global Molecular Imaging Market?
Growing Demand for On-time Disease Detection to Propel the Segment Growth
Increasing demand for on-time detection and treatment of diseases is expected to benefit the molecular diagnostic segment during the forecast period. The growing number of diagnostic centers owing to consolidation in the market is likely to contribute to the segmental growth in the forecast period.
Furthermore, increasing adoption of advanced technology and developed infrastructure are other factors contributing to the development of the segment.
Regional Analysis
How are Increasing Product Launches Strengthening the Molecular Imaging Market in North America?
According to the analysis, the global molecular imaging market is projected to be dominated by North America during the forecast period. In 2021, the region is likely to have accounted for the largest market share of about 33%. Domination of the region can be attributed to the presence of established players in the region taking various initiatives to launch new products.
Further, growing clearances of the product by the FDA are likely to widen the market growth scope in the coming time. For instance, in January 2019, United Imaging Healthcare announced the US FDA of uEXPLORER total-body scanner. It is the globe’s first medical imaging scanner that can capture a 3D image of the human body. Such factors are expected to benefit the global molecular imaging market.
How is Growing Technological Advancement Developing the Molecular Imaging Market in Europe?
According to the analysis, the market for molecular imaging in Europe is anticipated to display a CAGR of 4% during the forecast period. Development of the market can be attributed to the ongoing technological development in the market. For instance, in 2021, Koninklijke Philips launched the spectral detector-based Spectral Computed Tomography (CT) 7500 solution for accurate diagnosis.
Players receiving FDA clearances is another salient factor that is likely to develop the industry in the forecast period. For instance, in 2021, Siemens Healthineers received FDA clearance for the Biograph Vision Quadra, a CT scanner for clinical application. Such factors are likely to make a significant contribution to developing the market in Europe.
How is the Rising Demand for Imaging Equipment Benefitting the Global Molecular Imaging Market?
According to the analysis, APAC is projected to be the fastest-growing market for molecular imaging market during the forecast period. The region is likely to display a CAGR of 6% during the timeframe of 2022-2032.
The development of the regional market can be attributed to the increasing prevalence of chronic illness and the growing demand for developed diagnostic devices. Further, the rapid growth of healthcare infrastructure in evolving countries is another salient factor that can strengthen the industry in the coming time.
What Is The Role Of Startups In Developing The Global Molecular Imaging Market?
VoxelCloud (US), Aldoc (Israel), Qure.ai (India), Zebra Medical Vision (Israel), HeartFlow (US), Arterys (US), Kheiron Medical Technologies (UK), and Lunit (South Korea), among others, are some of the emerging names in the global molecular imaging market.
Recent Updates from the Startup Landscape:
- In March 2022, Healthtech Startup Qure.ai raised US$ 40 Million in a funding round led by Novo Holdings and HealthQuad. The existing investor MassMutual Ventures also participated in the round. The capital will be used to strengthen its reach in the US and Europe.
Competition Analysis
Key players in the global molecular imaging market include Hermes Medical Solutions, Bruker Corporation, GE Company, Fujifilm Holdings Corp., Siemens AG, Koninklijke Philips N.V., and Toshiba Medical System Corp.
Recent Developments in the Market:
- In September 2021, Hermes Medical Solutions and Isotopia Molecular Imaging announced a new collaboration with Isotopia to raise awareness and co-promote the benefits of dosimetry, personalized medicine, and radiopharmaceutical therapy.
- In February 2021, Royal Philips announced the acquisition of BioTelemetry, a US-based player that provides remote cardiac diagnostics and monitoring. The acquisition of BioTelemetry is a strong fit with Philips’ cardiac care portfolio, and its strategy to transform the delivery of care along the health continuum with integrated solutions.
Scope Of The Report
|
Attribute |
Details |
|
Molecular Imaging Market Forecast Period |
2022-2032 |
|
Molecular Imaging Market Historical Data Available for |
2017-2021 |
|
Molecular Imaging Market Analysis |
USD Million for Value and Volume in Units |
|
Molecular Imaging Market - Key Regions Covered |
North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA |
|
Molecular Imaging Market - Key Countries Covered |
U.S., Canada, Brazil, U.K., Mexico, Germany, France, Italy, Spain, BENELUX, Russia, Japan, India, China, Japan, South Korea, Thailand, Malaysia, Indonesia, Australia, New Zealand, GCC, and South Africa |
|
Molecular Imaging Market - Key Segments Covered |
Modality, Application, End User, Region |
|
Molecular Imaging Market - Key Companies Profiled |
|
|
Report Coverage |
Market Forecast, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives |
|
Customization & Pricing |
Available upon Request |
Frequently Asked Questions
The global molecular imaging market is expected to secure US$ 4.309 Billion in 2022.
The global molecular imaging market is expected to value at US$ 7.3 Billion by 2032.
The global molecular imaging market is likely to exhibit a CAGR of 5.41% during the forecast period.
In Europe, the molecular imaging market is expected to display a CAGR of 4% during the forecast period.
In 2021, the hospital segment is projected to have secured 46.5% of the global revenue.
In APAC, the molecular imaging market is expected to display a CAGR of 6% during the forecast period.
In 2021, the molecular imaging market in North America is expected to have claimed 33% of the global revenue.
Hermes Medical Solutions, Bruker Corporation, and GE Company are some of the renowned players in the global molecular imaging market.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusion
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Product Adoption / Usage Analysis
4.2. Strategic promotional strategies
5. COVID-19 Crisis Analysis
5.1. Current COVID19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 financial analysis
5.4. COVID19 and Impact Analysis, by Country
5.5. 2022 Market Scenario
5.6. Recovery Scenario – Short term, Midterm and Long Term Impact
6. Global Market Volume (‘000’ Units) Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Volume (‘000’ Units) Analysis, 2017-2021
6.2. Current and Future Market Volume (‘000’ Units) Projections, 2022-2032
6.2.1. Y-o-Y Growth Trend Analysis
7. Global Market - Pricing Analysis, 2022-2032
7.1. Regional Pricing Analysis By Modality
7.2. Pricing Break-up
7.2.1. Manufacturer Level Pricing
7.2.2. Distributor Level Pricing
7.3. Global Average Pricing Analysis Benchmark
8. Global Market Demand (in Value or Size in US$ Mn) Analysis 2017-2021 and Forecast, 2022-2032
8.1. Historical Market Value (US$ Mn) Analysis, 2017-2021
8.2. Current and Future Market Value (US$ Mn) Projections, 2022-2032
8.2.1. Y-o-Y Growth Trend Analysis
8.2.2. Absolute $ Opportunity Analysis
9. Market Background
9.1. Macro-Economic Factors
9.1.1. Global GDP Growth Outlook
9.1.2. Global Healthcare Expenditure Outlook
9.1.3. Income Per Capita Outlook
9.2. Forecast Factors - Relevance & Impact
9.2.1. Investment in medical infrastructure development
9.2.2. Emergence of alternative devices
9.2.3. Growth in commercial diagnostics application
9.2.4. Government support medical device research and development
9.2.5. Changing lifestyles
9.2.6. Epidemiology of cancer and other chronic diseases
9.3. Market Dynamics
9.3.1. Drivers
9.3.2. Restraints
9.3.3. Opportunity Analysis
10. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Modality
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Modality, 2017-2021
10.3. Current and Future Market Size (US$ Mn) and Volume Units Analysis and Forecast By Modality, 2021 - 2031
10.3.1. Positron Emission Tomography (PET)
10.3.2. Positron Emission Tomography- Computed Tomography (PET-CT)
10.3.3. Positron Emission Tomography- Magnetic Resonance (PET-MR)
10.3.4. Single Photon Emission Computed Tomography (SPECT)
10.3.5. Software
10.3.5.1. On Premises Solutions
10.3.5.2. Cloud Based Solutions
10.3.6. Magnetic Resonance
10.3.7. Molecular Ultrasound Imaging
10.4. Market Attractiveness Analysis By Modality
11. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Application
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Application, 2017-2021
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2022-2032
11.3.1. Cardiology
11.3.2. Oncology
11.3.3. Gastrointestinal Disorders
11.3.4. Neurology Disorders
11.3.5. Others
11.4. Market Attractiveness Analysis By Application
12. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by End User
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By End User, 2017-2021
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022-2032
12.3.1. Hospitals
12.3.1.1. 500+ Beds
12.3.1.2. 200-499 Beds
12.3.1.3. Less than 200 Beds
12.3.2. Ambulatory Surgical Centres
12.3.3. Diagnostic Centres
12.4. Market Attractiveness Analysis By End User
13. Global Market Analysis 2017-2021 and Forecast, 2022-2032, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2017-2021
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. MEA
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Modality
14.3.3. By Application
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
15. Latin America Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Modality
15.3.3. By Application
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
16. Europe Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. Russia
16.3.1.7. Rest of Europe
16.3.2. By Modality
16.3.3. By Application
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis
17. South Asia Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Indonesia
17.3.1.4. Malaysia
17.3.1.5. Rest of South Asia
17.3.2. By Modality
17.3.3. By Application
17.3.4. By End User
17.4. Market Attractiveness Analysis
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis
18. East Asia Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.4. Rest of East Asia
18.3.2. By Modality
18.3.3. By Application
18.3.4. By End User
18.4. Market Attractiveness Analysis
18.5. Key Market Participants - Intensity Mapping
18.6. Drivers and Restraints - Impact Analysis
19. Oceania Market Analysis 2017-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Modality
19.3.3. By Application
19.3.4. By End User
19.4. Market Attractiveness Analysis
19.5. Key Market Participants - Intensity Mapping
19.6. Drivers and Restraints - Impact Analysis
20. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032
20.1. Introduction
20.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017-2021
20.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2022-2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Turkey
20.3.1.3. South Africa
20.3.1.4. Rest of Middle East and Africa
20.3.2. By Modality
20.3.3. By Application
20.3.4. By End User
20.4. Market Attractiveness Analysis
20.5. Key Market Participants - Intensity Mapping
20.6. Drivers and Restraints - Impact Analysis
21. Key and Emerging Countries Market Analysis 2017-2021 and Forecast 2022-2032
21.1. Introduction
21.1.1. Market Value Proportion Analysis, By Key Countries
21.1.2. Global Vs. Country Growth Comparison
21.2. U.S. Market Analysis
21.2.1. By Modality
21.2.2. By Application
21.2.3. By End User
21.3. Canada Market Analysis
21.3.1. By Modality
21.3.2. By Application
21.3.3. By End User
21.4. Mexico Market Analysis
21.4.1. By Modality
21.4.2. By Application
21.4.3. By End User
21.5. Brazil Market Analysis
21.5.1. By Modality
21.5.2. By Application
21.5.3. By End User
21.6. U.K. Market Analysis
21.6.1. By Modality
21.6.2. By Application
21.6.3. By End User
21.7. Germany Market Analysis
21.7.1. By Modality
21.7.2. By Application
21.7.3. By End User
21.8. France Market Analysis
21.8.1. By Modality
21.8.2. By Application
21.8.3. By End User
21.9. Italy Market Analysis
21.9.1. By Modality
21.9.2. By Application
21.9.3. By End User
21.10. Spain Market Analysis
21.10.1. By Modality
21.10.2. By Application
21.10.3. By End User
21.11. BENELUX Market Analysis
21.11.1. By Modality
21.11.2. By Application
21.11.3. By End User
21.12. Russia Market Analysis
21.12.1. By Modality
21.12.2. By Application
21.12.3. By End User
21.13. Poland Market Analysis
21.13.1. By Modality
21.13.2. By Application
21.13.3. By End User
21.14. China Market Analysis
21.14.1. By Modality
21.14.2. By Application
21.14.3. By End User
21.15. Japan Market Analysis
21.15.1. By Modality
21.15.2. By Application
21.15.3. By End User
21.16. South Korea Market Analysis
21.16.1. By Modality
21.16.2. By Application
21.16.3. By End User
21.17. India Market Analysis
21.17.1. By Modality
21.17.2. By Application
21.17.3. By End User
21.18. ASEAN Market Analysis
21.18.1. By Modality
21.18.2. By Application
21.18.3. By End User
21.19. Australia Market Analysis
21.19.1. By Modality
21.19.2. By Application
21.19.3. By End User
21.20. New Zealand Market Analysis
21.20.1. By Modality
21.20.2. By Application
21.20.3. By End User
21.21. GCC Countries Market Analysis
21.21.1. By Modality
21.21.2. By Application
21.21.3. By End User
21.22. South Africa Market Analysis
21.22.1. By Modality
21.22.2. By Application
21.22.3. By End User
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies
22.2. Market Share Analysis of Top Players
22.3. Competition Intensity Mapping By Market Taxonomy
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Benchmarking
23.3. Competition Deep Dive
23.3.1. GE Company
23.3.1.1. Overview
23.3.1.2. Product Portfolio
23.3.1.3. Financial Overview
23.3.1.4. Strategy Overview
23.3.1.5. SWOT
23.3.1.6. Key Developments
23.3.2. Fujifilm Holdings Corporation
23.3.2.1. Overview
23.3.2.2. Product Portfolio
23.3.2.3. Financial Overview
23.3.2.4. Strategy Overview
23.3.2.5. SWOT
23.3.2.6. Key Developments
23.3.3. Siemens AG
23.3.3.1. Overview
23.3.3.2. Product Portfolio
23.3.3.3. Financial Overview
23.3.3.4. Strategy Overview
23.3.3.5. SWOT
23.3.3.6. Key Developments
23.3.4. Koninklijke Philips N.V.
23.3.4.1. Overview
23.3.4.2. Product Portfolio
23.3.4.3. Financial Overview
23.3.4.4. Strategy Overview
23.3.4.5. SWOT
23.3.4.6. Key Developments
23.3.5. Toshiba Medical System Corp.
23.3.5.1. Overview
23.3.5.2. Product Portfolio
23.3.5.3. Financial Overview
23.3.5.4. Strategy Overview
23.3.5.5. SWOT
23.3.5.6. Key Developments
23.3.6. Hitachi Medical Corp.
23.3.6.1. Overview
23.3.6.2. Product Portfolio
23.3.6.3. Financial Overview
23.3.6.4. Strategy Overview
23.3.6.5. SWOT
23.3.6.6. Key Developments
23.3.7. Medisco Ltd.
23.3.7.1. Overview
23.3.7.2. Product Portfolio
23.3.7.3. Financial Overview
23.3.7.4. Strategy Overview
23.3.7.5. SWOT
23.3.7.6. Key Developments
23.3.8. Positrion Corporation
23.3.8.1. Overview
23.3.8.2. Product Portfolio
23.3.8.3. Financial Overview
23.3.8.4. Strategy Overview
23.3.8.5. SWOT
23.3.8.6. Key Developments
23.3.9. Esaote SpA
23.3.9.1. Overview
23.3.9.2. Product Portfolio
23.3.9.3. Financial Overview
23.3.9.4. Strategy Overview
23.3.9.5. SWOT
23.3.9.6. Key Developments
23.3.10. Carestream Health Inc.
23.3.10.1. Overview
23.3.10.2. Product Portfolio
23.3.10.3. Financial Overview
23.3.10.4. Strategy Overview
23.3.10.5. SWOT
23.3.10.6. Key Developments
23.3.11. Mirada Medical Limited
23.3.11.1. Overview
23.3.11.2. Product Portfolio
23.3.11.3. Financial Overview
23.3.11.4. Strategy Overview
23.3.11.5. SWOT
23.3.11.6. Key Developments
23.3.12. MIM Software Inc.
23.3.12.1. Overview
23.3.12.2. Product Portfolio
23.3.12.3. Financial Overview
23.3.12.4. Strategy Overview
23.3.12.5. SWOT
23.3.12.6. Key Developments
23.3.13. Bruker Corporation
23.3.13.1. Overview
23.3.13.2. Product Portfolio
23.3.13.3. Financial Overview
23.3.13.4. Strategy Overview
23.3.13.5. SWOT
23.3.13.6. Key Developments
23.3.14. Hermes Medical Solutions
23.3.14.1. Overview
23.3.14.2. Product Portfolio
23.3.14.3. Financial Overview
23.3.14.4. Strategy Overview
23.3.14.5. SWOT
23.3.14.6. Key Developments
24. Assumptions and Acronyms Used
25. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global Market Demand (in Volume 000'Units) Analysis- and Opportunity Assessment 2017-2032, By Modality
Table 02: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2017-2032, By Modality
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017-2032, By Application
Table 04: Global Market Value (US$ Mn) Analysis- and Opportunity Assessment 2017-2032, By End User
Table 05: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2017-2032, By Region
Table 06: North America Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 07: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 08: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 09: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 10: North America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 11: Latin America Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 12: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 13: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 14: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 15: Latin America Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 16: Europe Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 17: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 18: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 19: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 20: Europe Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 21: South Asia Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 22: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 23: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 24: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 25: South Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 26: East Asia Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 27: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 28: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 29: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 30: East Asia Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 31: Oceania Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 32: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 33: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 34: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 35: Oceania Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Table 36: Middle East and Africa Market Demand (in Volume 000'Units) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 37: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Modality
Table 38: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Application
Table 39: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By End User
Table 40: Middle East and Africa Market Value (US$ Mn) Analysis 2017-2021 and Forecast 2022-2032, By Country
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global Market Historical Market Volume Analysis, 2017-2021
Figure 02: Country Average Pricing Analysis Benchmark USD/ Per Unit (2022)
Figure 03: Global Current and Future Market Volume, 2022-2032 & Y-o-Y Growth Trend Analysis
Figure 04: Global Market Value Analysis (US$ Mn), 2017-2021
Figure 05: Global Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 06: Global Market Absolute $ Opportunity, 2022-2032
Figure 07: Global Market Share Analysis (%), By Modality, 2022 & 2032
Figure 08: Global Market Y-o-Y Analysis (%), By Modality, 2022-2032
Figure 09: Global Market Attractiveness Analysis by Modality, 2022-2032
Figure 10: Global Market Share Analysis (%), By Application, 2022 & 2032
Figure 11: Global Market Y-o-Y Analysis (%), By Application, 2022-2032
Figure 12: Global Market Attractiveness Analysis by Application, 2022-2032
Figure 13: Global Market Share Analysis (%), By End User, 2022 & 2032
Figure 14: Global Market Y-o-Y Analysis (%), By End User, 2022-2032
Figure 15: Global Market Attractiveness Analysis by End User, 2022-2032
Figure 16: Global Market Share Analysis (%), By Region, 2022 & 2032
Figure 17: Global Market Y-o-Y Analysis (%), By Region, 2022-2032
Figure 18: Global Market Attractiveness Analysis by Region, 2022-2032
Figure 19: North America Market Value Analysis (US$ Mn), 2017-2021
Figure 20: North America Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 21: North America Market Share, By Modality (2022)
Figure 22: North America Market Share, By End User (2022)
Figure 23: North America Market Share, By Application (2022)
Figure 24: North America Market Share, By Country (2022)
Figure 25: North America Market Attractiveness Analysis by Modality, 2022-2032
Figure 26: North America Market Attractiveness Analysis by Application, 2022-2032
Figure 27: North America Market Attractiveness Analysis by End User, 2022-2032
Figure 28: North America Market Attractiveness Analysis by Country, 2022-2032
Figure 29: Latin America Market Value Analysis (US$ Mn), 2017-2021
Figure 30: Latin America Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 31: Latin America Market Share, By Modality (2022)
Figure 32: Latin America Market Share, By End User (2022)
Figure 33: Latin America Market Share, By Application (2022)
Figure 34: Latin America Market Share, By Country (2022)
Figure 35: Latin America Market Attractiveness Analysis by Modality, 2022-2032
Figure 36: Latin America Market Attractiveness Analysis by Application, 2022-2032
Figure 37: Latin America Market Attractiveness Analysis by End User, 2022-2032
Figure 38: Latin America Market Attractiveness Analysis by Country, 2022-2032
Figure 39: Europe Market Value Analysis (US$ Mn), 2017-2021
Figure 40: Europe Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 41: Europe Market Share, By Modality (2022)
Figure 42: Europe Market Share, By End User (2022)
Figure 43: Europe Market Share, By Application (2022)
Figure 44: Europe Market Share, By Country (2022)
Figure 45: Europe Market Attractiveness Analysis by Modality, 2022-2032
Figure 46: Europe Market Attractiveness Analysis by Application, 2022-2032
Figure 47: Europe Market Attractiveness Analysis by End User, 2022-2032
Figure 48: Europe Market Attractiveness Analysis by Country, 2022-2032
Figure 49: South Asia Market Value Analysis (US$ Mn), 2017-2021
Figure 50: South Asia Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 51: South Asia Market Share, By Modality (2022)
Figure 52: South Asia Market Share, By End User (2022)
Figure 53: South Asia Market Share, By Application (2022)
Figure 54: South Asia Market Share, By Country (2022)
Figure 55: South Asia Market Attractiveness Analysis by Modality, 2022-2032
Figure 56: South Asia Market Attractiveness Analysis by Application, 2022-2032
Figure 57: South Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 58: South Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 59: East Asia Market Value Analysis (US$ Mn), 2017-2021
Figure 60: East Asia Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 61: East Asia Market Share, By Modality (2022)
Figure 62: East Asia Market Share, By End User (2022)
Figure 63: East Asia Market Share, By Application (2022)
Figure 64: East Asia Market Share, By Country (2022)
Figure 65: East Asia Market Attractiveness Analysis by Modality, 2022-2032
Figure 66: East Asia Market Attractiveness Analysis by Application, 2022-2032
Figure 67: East Asia Market Attractiveness Analysis by End User, 2022-2032
Figure 68: East Asia Market Attractiveness Analysis by Country, 2022-2032
Figure 69: Oceania Market Value Analysis (US$ Mn), 2017-2021
Figure 70: Oceania Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 71: Oceania Market Share, By Modality (2022)
Figure 72: Oceania Market Share, By End User (2022)
Figure 73: Oceania Market Share, By Application (2022)
Figure 74: Oceania Market Share, By Country (2022)
Figure 75: Oceania Market Attractiveness Analysis by Modality, 2022-2032
Figure 76: Oceania Market Attractiveness Analysis by Application, 2022-2032
Figure 77: Oceania Market Attractiveness Analysis by End User, 2022-2032
Figure 78: Oceania Market Attractiveness Analysis by Country, 2022-2032
Figure 79: Middle East and Africa Market Value Analysis (US$ Mn), 2017-2021
Figure 80: Middle East and Africa Market Value Forecast (US$ Mn), 2022-2032 & Y-o-Y Growth (%), 2022-2032
Figure 81: Middle East and Africa Market Share, By Modality (2022)
Figure 82: Middle East and Africa Market Share, By End User (2022)
Figure 83: Middle East and Africa Market Share, By Application (2022)
Figure 84: Middle East and Africa Market Share, By Country (2022)
Figure 85: Middle East and Africa Market Attractiveness Analysis by Modality, 2022-2032
Figure 86: Middle East and Africa Market Attractiveness Analysis by Application, 2022-2032
Figure 87: Middle East and Africa Market Attractiveness Analysis by End User, 2022-2032
Figure 88: Middle East and Africa Market Attractiveness Analysis by Country, 2022-2032
Figure 89: U.S Market Value Proportion Analysis, 2022
Figure 90: Global Vs. U.S Growth Comparison
Figure 91: U.S. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 92: U.S. Market Share Analysis (%) By Application, 2022 & 2032
Figure 93: U.S. Market Share Analysis (%) By End User, 2022 & 2032
Figure 94: Canada Market Value Proportion Analysis, 2022
Figure 95: Global Vs. Canada Growth Comparison
Figure 96: Canada. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 97: Canada. Market Share Analysis (%) By Application, 2022 & 2032
Figure 98: Canada. Market Share Analysis (%) By End User, 2022 & 2032
Figure 99: Mexico Market Value Proportion Analysis, 2022
Figure 100: Global Vs. Mexico Growth Comparison
Figure 101: Mexico. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 102: Mexico. Market Share Analysis (%) By Application, 2022 & 2032
Figure 103: Mexico. Market Share Analysis (%) By End User, 2022 & 2032
Figure 104: Brazil Market Value Proportion Analysis, 2022
Figure 105: Global Vs. Brazil Growth Comparison
Figure 106: Brazil. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 107: Brazil. Market Share Analysis (%) By Application, 2022 & 2032
Figure 108: Brazil. Market Share Analysis (%) By End User, 2022 & 2032
Figure 109: U.K. Market Value Proportion Analysis, 2022
Figure 110: Global Vs. U.K. Growth Comparison
Figure 111: U.K. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 112: U.K. Market Share Analysis (%) By Application, 2022 & 2032
Figure 113: U.K. Market Share Analysis (%) By End User, 2022 & 2032
Figure 114: Germany Market Value Proportion Analysis, 2022
Figure 115: Global Vs. Germany Growth Comparison
Figure 116: Germany. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 117: Germany. Market Share Analysis (%) By Application, 2022 & 2032
Figure 118: Germany. Market Share Analysis (%) By End User, 2022 & 2032
Figure 119: France Market Value Proportion Analysis, 2022
Figure 120: Global Vs. France Growth Comparison
Figure 121: France. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 122: France. Market Share Analysis (%) By Application, 2022 & 2032
Figure 123: France. Market Share Analysis (%) By End User, 2022 & 2032
Figure 124: Italy Market Value Proportion Analysis, 2022
Figure 125: Global Vs. Italy Growth Comparison
Figure 126: Italy. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 127: Italy. Market Share Analysis (%) By Application, 2022 & 2032
Figure 128: Italy. Market Share Analysis (%) By End User, 2022 & 2032
Figure 129: Spain Market Value Proportion Analysis, 2022
Figure 130: Global Vs. Spain Growth Comparison
Figure 131: Spain. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 132: Spain. Market Share Analysis (%) By Application, 2022 & 2032
Figure 133: Spain. Market Share Analysis (%) By End User, 2022 & 2032
Figure 134: Russia Market Value Proportion Analysis, 2022
Figure 135: Global Vs. Russia Growth Comparison
Figure 136: Russia. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 137: Russia. Market Share Analysis (%) By Application, 2022 & 2032
Figure 138: Russia. Market Share Analysis (%) By End User, 2022 & 2032
Figure 139: BENELUX Market Value Proportion Analysis, 2022
Figure 140: Global Vs. BENELUX Growth Comparison
Figure 141: BENELUX. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 142: BENELUX. Market Share Analysis (%) By Application, 2022 & 2032
Figure 143: BENELUX. Market Share Analysis (%) By End User, 2022 & 2032
Figure 144: Poland Market Value Proportion Analysis, 2022
Figure 145: Global Vs. Poland Growth Comparison
Figure 146: Poland. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 147: Poland. Market Share Analysis (%) By Application, 2022 & 2032
Figure 148: Poland. Market Share Analysis (%) By End User, 2022 & 2032
Figure 149: China Market Value Proportion Analysis, 2022
Figure 150: Global Vs. China Growth Comparison
Figure 151: China. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 152: China. Market Share Analysis (%) By Application, 2022 & 2032
Figure 153: China. Market Share Analysis (%) By End User, 2022 & 2032
Figure 154: Japan Market Value Proportion Analysis, 2022
Figure 155: Global Vs. Japan Growth Comparison
Figure 156: Japan. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 157: Japan. Market Share Analysis (%) By Application, 2022 & 2032
Figure 158: Japan. Market Share Analysis (%) By End User, 2022 & 2032
Figure 159: South Korea Market Value Proportion Analysis, 2022
Figure 160: Global Vs. South Korea Growth Comparison
Figure 161: South Korea. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 162: South Korea. Market Share Analysis (%) By Application, 2022 & 2032
Figure 163: South Korea. Market Share Analysis (%) By End User, 2022 & 2032
Figure 164: India Market Value Proportion Analysis, 2022
Figure 165: Global Vs. India Growth Comparison
Figure 166: India. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 167: India. Market Share Analysis (%) By Application, 2022 & 2032
Figure 168: India. Market Share Analysis (%) By End User, 2022 & 2032
Figure 169: ASEAN Market Value Proportion Analysis, 2022
Figure 170: Global Vs. ASEAN Growth Comparison
Figure 171: ASEAN. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 172: ASEAN. Market Share Analysis (%) By Application, 2022 & 2032
Figure 173: ASEAN. Market Share Analysis (%) By End User, 2022 & 2032
Figure 174: Australia Market Value Proportion Analysis, 2022
Figure 175: Global Vs. Australia Growth Comparison
Figure 176: Australia. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 177: Australia. Market Share Analysis (%) By Application, 2022 & 2032
Figure 178: Australia. Market Share Analysis (%) By End User, 2022 & 2032
Figure 179: New Zealand Market Value Proportion Analysis, 2022
Figure 180: Global Vs. New Zealand Growth Comparison
Figure 181: New Zealand. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 182: New Zealand. Market Share Analysis (%) By Application, 2022 & 2032
Figure 183: New Zealand. Market Share Analysis (%) By End User, 2022 & 2032
Figure 184: GCC Countries Market Value Proportion Analysis, 2022
Figure 185: Global Vs. GCC Countries Growth Comparison
Figure 186: GCC Countries. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 187: GCC Countries. Market Share Analysis (%) By Application, 2022 & 2032
Figure 188: GCC Countries. Market Share Analysis (%) By End User, 2022 & 2032
Figure 189: South Africa Market Value Proportion Analysis, 2022
Figure 190: Global Vs. South Africa Growth Comparison
Figure 191: South Africa. Market Share Analysis (%) By Modality, 2022 & 2032
Figure 192: South Africa. Market Share Analysis (%) By Application, 2022 & 2032
Figure 193: South Africa. Market Share Analysis (%) By End User, 2022 & 2032
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
